ACADIA Pharmaceuticals ACAD reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ACADIA Pharmaceuticals missed estimated earnings by -7.000000000000001%, reporting an EPS of $0.28 versus an estimate of $0.3.
Revenue was up $94.55 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 5.0% increase in the share price the next day.
Here's a look at ACADIA Pharmaceuticals's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.43 | -0.08 | -0.21 | -0.24 |
| EPS Actual | -0.40 | 0.01 | -0.27 | -0.26 |
| Revenue Estimate | 189.51M | 157.81M | 120.29M | 134.07M |
| Revenue Actual | 211.70M | 165.24M | 118.46M | 136.49M |
To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
